Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Bramah, Singh"'
Publikováno v:
EP Lab Digest; Nov2014, Vol. 14 Issue 11, p32-32, 2/3p
Autor:
Singh, B.1
Publikováno v:
Drugs. Feb2000, Vol. 59 Issue 2, p278-279. 2p.
Autor:
Amit, Vora, Dilip, Karnad, Venkat, Goyal, Ajay, Naik, Anup, Gupta, Yash, Lokhandwala, Hema, Kulkarni, Bramah, Singh
Publikováno v:
Indian heart journal. 56(2)
Patients with rheumatic heart disease and atrial fibrillation incur significant morbidity and mortality. It is not known which approach, rate control or maintenance of sinus rhythm might be most appropriate. The present study was undertaken to compar
Publikováno v:
American heart journal. 114(4 Pt 1)
Esmolol (Brevibloc) is an intravenous, short-acting, titratable, cardioselective beta blocker with a very rapid onset and offset of action (t1/2 = 9.2 minutes). Esmolol-induced beta blockade can be maintained as long as infusion is continued. It exhi
Publikováno v:
European Heart Journal; 3/7/2019, Vol. 40 Issue 10, p797-798, 2p, 1 Color Photograph
Autor:
KHITRI, AVINASH R.1 (AUTHOR), ALIOT, ETIENNE M.2 (AUTHOR), CAPUCCI, ALESSANDRO3 (AUTHOR), CONNOLLY, STUART J.4 (AUTHOR), CRIJNS, HARRY5 (AUTHOR), HOHNLOSER, STEFAN H.6 (AUTHOR), KULAKOWSKI, PIOTR7 (AUTHOR), ROY, DENIS8 (AUTHOR), RADZIK, DAVID9 (AUTHOR), KOWEY, PETER R.1 (AUTHOR)
Publikováno v:
Journal of Cardiovascular Electrophysiology. May2012, Vol. 23 Issue 5, p462-472. 11p. 1 Diagram, 6 Charts, 1 Graph.
Publikováno v:
Journal of Human Hypertension. Jan2002, Vol. 16 Issue 1, p5. 7p.
Autor:
Cavalla, David
Publikováno v:
Off-label prescribing - Justifying unapproved medicine; 2015, p125-142, 18p
Autor:
Hale, Sharon L., Kloner, Robert A.
Publikováno v:
Journal of Cardiovascular Pharmacology & Therapeutics; Mar2010, Vol. 15 Issue 1, p60-67, 8p
Autor:
Elizari, Marcelo V.
Publikováno v:
Annals of Noninvasive Electrocardiology; Jan2008, Vol. 13 Issue 1, p86-91, 6p, 1 Black and White Photograph